Glutamic oxaloacetic transaminase 1
GOT1proteinCytoplasmic transaminase released from cardiomyocyte necrosis reflecting ischemic myocardial injury.
Pathway placement
Cascade stepMyocardial injury (shared endpoint)
Confidencemedium
RationaleCytoplasmic enzyme released during myocardial necrosis; AMI-associated metabolic injury marker.
Druggability
DruggableYes
Known drugs / candidates0
Small-molecule tractableYes
Antibody tractableNo
EnsemblENSG00000120053
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Literature evidence(2)
- Plasma proteomics implicate glutamic oxaloacetic transaminases as potential markers for acute myocardial infarction.Journal of proteomics · 2024 · PMID 39173902 · doi
- A plasma proteomic approach in patients with heart failure after acute myocardial infarction: insights into the pathogenesis and progression of the disease.Frontiers in cardiovascular medicine · 2023 · PMID 37265567 · doi